These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
385 related articles for article (PubMed ID: 21468088)
1. Neurovascular function in Alzheimer's disease patients and experimental models. Nicolakakis N; Hamel E J Cereb Blood Flow Metab; 2011 Jun; 31(6):1354-70. PubMed ID: 21468088 [TBL] [Abstract][Full Text] [Related]
2. Pioglitazone improves reversal learning and exerts mixed cerebrovascular effects in a mouse model of Alzheimer's disease with combined amyloid-β and cerebrovascular pathology. Papadopoulos P; Rosa-Neto P; Rochford J; Hamel E PLoS One; 2013; 8(7):e68612. PubMed ID: 23874687 [TBL] [Abstract][Full Text] [Related]
3. Strong Impact of Chronic Cerebral Hypoperfusion on Neurovascular Unit, Cerebrovascular Remodeling, and Neurovascular Trophic Coupling in Alzheimer's Disease Model Mouse. Shang J; Yamashita T; Zhai Y; Nakano Y; Morihara R; Fukui Y; Hishikawa N; Ohta Y; Abe K J Alzheimers Dis; 2016 Mar; 52(1):113-26. PubMed ID: 27060955 [TBL] [Abstract][Full Text] [Related]
4. Transgenic mice overexpressing APP and transforming growth factor-beta1 feature cognitive and vascular hallmarks of Alzheimer's disease. Ongali B; Nicolakakis N; Lecrux C; Aboulkassim T; Rosa-Neto P; Papadopoulos P; Tong XK; Hamel E Am J Pathol; 2010 Dec; 177(6):3071-80. PubMed ID: 21088218 [TBL] [Abstract][Full Text] [Related]
5. Neurovascular dysfunction and faulty amyloid β-peptide clearance in Alzheimer disease. Sagare AP; Bell RD; Zlokovic BV Cold Spring Harb Perspect Med; 2012 Oct; 2(10):. PubMed ID: 23028132 [TBL] [Abstract][Full Text] [Related]
6. Neurovascular dysfunction and neurodegeneration in dementia and Alzheimer's disease. Nelson AR; Sweeney MD; Sagare AP; Zlokovic BV Biochim Biophys Acta; 2016 May; 1862(5):887-900. PubMed ID: 26705676 [TBL] [Abstract][Full Text] [Related]
7. Neurovascular uncoupling in the triple transgenic model of Alzheimer's disease: Impaired cerebral blood flow response to neuronal-derived nitric oxide signaling. Lourenço CF; Ledo A; Barbosa RM; Laranjinha J Exp Neurol; 2017 May; 291():36-43. PubMed ID: 28161255 [TBL] [Abstract][Full Text] [Related]
8. Twendee X Ameliorates Phosphorylated Tau, α-Synuclein and Neurovascular Dysfunction in Alzheimer's Disease Transgenic Mice With Chronic Cerebral Hypoperfusion. Liu X; Yamashita T; Shang J; Shi X; Morihara R; Huang Y; Sato K; Takemoto M; Hishikawa N; Ohta Y; Abe K J Stroke Cerebrovasc Dis; 2019 Oct; 28(10):104310. PubMed ID: 31383622 [TBL] [Abstract][Full Text] [Related]
9. Age‑ and brain region‑associated alterations of cerebral blood flow in early Alzheimer's disease assessed in AβPPSWE/PS1ΔE9 transgenic mice using arterial spin labeling. Guo Y; Li X; Zhang M; Chen N; Wu S; Lei J; Wang Z; Wang R; Wang J; Liu H Mol Med Rep; 2019 Apr; 19(4):3045-3052. PubMed ID: 30816468 [TBL] [Abstract][Full Text] [Related]
10. Impaired neurovascular coupling in the APPxPS1 mouse model of Alzheimer's disease. Rancillac A; Geoffroy H; Rossier J Curr Alzheimer Res; 2012 Dec; 9(10):1221-30. PubMed ID: 22799606 [TBL] [Abstract][Full Text] [Related]
11. β-Amyloid, cholinergic transmission, and cerebrovascular system -- a developmental study in a mouse model of Alzheimer's disease. Kuznetsova E; Schliebs R Curr Pharm Des; 2013; 19(38):6749-65. PubMed ID: 23530514 [TBL] [Abstract][Full Text] [Related]
12. Neural stem cell therapy for neurovascular injury in Alzheimer's disease. Boese AC; Hamblin MH; Lee JP Exp Neurol; 2020 Feb; 324():113112. PubMed ID: 31730762 [TBL] [Abstract][Full Text] [Related]
13. Mitochondria and vascular lesions as a central target for the development of Alzheimer's disease and Alzheimer disease-like pathology in transgenic mice. Aliev G; Seyidova D; Lamb BT; Obrenovich ME; Siedlak SL; Vinters HV; Friedland RP; LaManna JC; Smith MA; Perry G Neurol Res; 2003 Sep; 25(6):665-74. PubMed ID: 14503022 [TBL] [Abstract][Full Text] [Related]
15. Characterization of Impaired Cerebrovascular Structure in APP/PS1 Mouse Brains. Ahn KC; Learman CR; Dunbar GL; Maiti P; Jang WC; Cha HC; Song MS Neuroscience; 2018 Aug; 385():246-254. PubMed ID: 29777753 [TBL] [Abstract][Full Text] [Related]
16. The Neurovascular Unit Dysfunction in Alzheimer's Disease. Soto-Rojas LO; Pacheco-Herrero M; Martínez-Gómez PA; Campa-Córdoba BB; Apátiga-Pérez R; Villegas-Rojas MM; Harrington CR; de la Cruz F; Garcés-Ramírez L; Luna-Muñoz J Int J Mol Sci; 2021 Feb; 22(4):. PubMed ID: 33670754 [TBL] [Abstract][Full Text] [Related]
17. The role of perivascular innervation and neurally mediated vasoreactivity in the pathophysiology of Alzheimer's disease. Nizari S; Romero IA; Hawkes CA Clin Sci (Lond); 2017 Jun; 131(12):1207-1214. PubMed ID: 28566449 [TBL] [Abstract][Full Text] [Related]
18. Endothelial Mitochondrial Dysfunction in Cerebral Amyloid Angiopathy and Alzheimer's Disease. Parodi-Rullán R; Sone JY; Fossati S J Alzheimers Dis; 2019; 72(4):1019-1039. PubMed ID: 31306129 [TBL] [Abstract][Full Text] [Related]
19. Attenuation of functional hyperemia to visual stimulation in mild Alzheimer's disease and its sensitivity to cholinesterase inhibition. Janik R; Thomason LA; Chaudhary S; Dorr A; Scouten A; Schwindt G; Masellis M; Stanisz GJ; Black SE; Stefanovic B Biochim Biophys Acta; 2016 May; 1862(5):957-65. PubMed ID: 26521151 [TBL] [Abstract][Full Text] [Related]
20. Vascular β-amyloid and early astrocyte alterations impair cerebrovascular function and cerebral metabolism in transgenic arcAβ mice. Merlini M; Meyer EP; Ulmann-Schuler A; Nitsch RM Acta Neuropathol; 2011 Sep; 122(3):293-311. PubMed ID: 21688176 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]